DISPOSITION OF GLYCOSIDASE INHIBITORS IN THE ISOLATED-PERFUSED RAT-LIVER - HEPATOBILIARY AND SUBCELLULAR CONCENTRATION GRADIENTS OF 1-DEOXYMANNOJIRIMYCIN AND N-METHYL-1-DEOXYNOJIRIMYCIN
Ed. Faber et al., DISPOSITION OF GLYCOSIDASE INHIBITORS IN THE ISOLATED-PERFUSED RAT-LIVER - HEPATOBILIARY AND SUBCELLULAR CONCENTRATION GRADIENTS OF 1-DEOXYMANNOJIRIMYCIN AND N-METHYL-1-DEOXYNOJIRIMYCIN, Pharmaceutical research, 11(1), 1994, pp. 144-150
The hepatic disposition of two glycosidase inhibitors was studied in t
he isolated perfused rat liver and after subcellular fractionation. Th
e mannosidase inhibitor 1-deoxymannojirimycin (dMM) and the glucosidas
e inhibitor N-methyl-1-deoxynojirimycin (MedNM) exhibited minimal bind
ing to albumin and reached liver concentrations that approximately equ
aled their medium concentrations, after 30 min (MedNM) or 90 min (dMM)
. Within 2 hr 0.5% of the dose of MedNM and 2.9% of dMM were excreted
in bile. No metabolites were found for MedNM, whereas minor (bio)degra
dation was inferred for dMM. After subcellular fractionation, dMM and
MedNM were found predominantly in the cytosolic fraction. Compared to
the other particulate fractions, MedNM was elevated in the microsomal
fraction. and both compounds were slightly enriched in the lysosomal f
raction. We conclude that dMM and MedNM will likely inhibit liver enzy
mes when sufficiently high plasma levels are reached.